Related Experiment Video
Updated: May 31, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Molecular and Genetic Aspects of Lipid Metabolism Disorders and Potential Targets for Gene Therapy
Elvira R Akhmetzyanova1, Anna V Timofeeva1, Danil R Gallyamov1
1OpenLab Gene and Cell Technology, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Insights
Cardiovascular diseases linked to lipid metabolism disorders are a global health crisis. Gene therapy offers promising new strategies for treating these conditions by targeting underlying genetic and lifestyle factors.
Area of Science:
- Biochemistry
- Genetics
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of global mortality and disability.
- Impaired lipid metabolism, both primary (genetic) and secondary (lifestyle-induced), is a significant contributor to CVDs.
- Understanding lipid metabolism pathways is crucial for developing effective therapeutic interventions.
Purpose of the Study:
- To review potential therapeutic targets for lipid metabolism disorders.
- To summarize current gene therapy approaches for treating lipid metabolism-related diseases.
- To explore the future potential of gene therapy in managing cardiovascular disease.
Main Methods:
- Literature review of studies on lipid metabolism, cardiovascular disease, and gene therapy.
- Analysis of genetic factors and lifestyle influences on lipid metabolism.
- Examination of existing and emerging gene therapy strategies.
Main Results:
- Identification of key genes and pathways involved in lipid metabolism disorders.
- Overview of various gene therapy techniques applicable to metabolic diseases.
- Discussion of the potential of gene therapy to address both primary and secondary lipid disorders.
Conclusions:
- Targeting lipid metabolism offers a viable strategy for CVD prevention and treatment.
- Gene therapy presents a promising frontier for managing complex lipid metabolism disorders.
- Further research and technological advancements in gene therapy are expected to expand treatment options for cardiovascular health.
Abstract:
Diseases associated with impaired lipid metabolism are major contributors to the rising global burden of cardiovascular disease. Over the past several decades, cardiovascular diseases have consistently remained the leading cause of mortality and disability worldwide. Many of these conditions are linked to mutations in genes encoding proteins that regulate lipid metabolism. At the same time, secondary lipid metabolism disorders can arise from unhealthy lifestyles and harmful habits that initiate pathological processes. Understanding the mechanisms underlying these processes is essential for developing new therapeutic strategies for both primary and secondary lipid metabolism disorders. The rapid advancement of innovative gene therapy approaches has introduced novel strategies for treating a wide range of diseases, and further progress in these technologies is expected to broaden the spectrum of target conditions. This review will examine potential therapeutic targets for lipid metabolism disorders and summarize existing gene therapy approaches.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Catabolism
